Net Income Common - Epizyme Inc (F:EPE) - Alpha Spread
E

Epizyme Inc
F:EPE

Watchlist Manager
Epizyme Inc
F:EPE
Watchlist
Price: 559 EUR 3.33% Market Closed
Market Cap: 92.2B EUR
Have any thoughts about
Epizyme Inc?
Write Note

Epizyme Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Epizyme Inc
Net Income (Common) Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
E
Epizyme Inc
F:EPE
Net Income (Common)
-$207.7m
CAGR 3-Years
-15%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Net Income (Common)
$5.3B
CAGR 3-Years
-7%
CAGR 5-Years
5%
CAGR 10-Years
2%
Gilead Sciences Inc
NASDAQ:GILD
Net Income (Common)
$1.1B
CAGR 3-Years
-41%
CAGR 5-Years
-29%
CAGR 10-Years
-18%
Amgen Inc
NASDAQ:AMGN
Net Income (Common)
$3.1B
CAGR 3-Years
-18%
CAGR 5-Years
-17%
CAGR 10-Years
-5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Income (Common)
-$489.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
0%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Income (Common)
$4.3B
CAGR 3-Years
-11%
CAGR 5-Years
16%
CAGR 10-Years
27%

See Also

What is Epizyme Inc's Net Income (Common)?
Net Income (Common)
-207.7m USD

Based on the financial report for Jun 30, 2022, Epizyme Inc's Net Income (Common) amounts to -207.7m USD.

What is Epizyme Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-12%

Over the last year, the Net Income (Common) growth was 19%. The average annual Net Income (Common) growth rates for Epizyme Inc have been -15% over the past three years , -12% over the past five years .

Back to Top